Skip to Main Content

Paper Details

Renal medullary carcinomas depend upon <i>SMARCB1</i> loss and are sensitive to proteasome inhibition.
Elife
32
2019
Author NameAffiliation
Jeremiah WalaBroad Institute of Harvard and MIT
Jeremiah WalaBroad Institute of Harvard and MIT
Guillaume KugenerBroad Institute of Harvard and MIT
Adam TracyBroad Institute of Harvard and MIT
Brian D CromptonBoston Children's Hospital
Brian D CromptonBroad Institute of Harvard and MIT
Brian D CromptonDana-Farber Cancer Institute
Katherine A JanewayBoston Children's Hospital
Katherine A JanewayDana-Farber Cancer Institute
Pratiti BandopadhayayBoston Children's Hospital
Pratiti BandopadhayayBroad Institute of Harvard and MIT
Pratiti BandopadhayayDana-Farber Cancer Institute
Paul A ClemonsBroad Institute of Harvard and MIT
Paul A ClemonsBroad Institute of Harvard and MIT
Stuart L SchreiberBroad Institute of Harvard and MIT
Stuart L SchreiberBroad Institute of Harvard and MIT
David E RootBroad Institute of Harvard and MIT
David E RootBroad Institute of Harvard and MIT
Elizabeth A MullenBoston Children's Hospital
Elizabeth A MullenDana-Farber Cancer Institute
Charles W M RobertsSt. Jude Children's Research Hospital
Rameen BeroukhimDana-Farber Cancer Institute
Rameen BeroukhimBrigham and Women's Hospital
Rameen BeroukhimBroad Institute of Harvard and MIT
Keith L LigonDana-Farber Cancer Institute
Keith L LigonBrigham and Women's Hospital
Keith L LigonBroad Institute of Harvard and MIT
Jesse S BoehmBroad Institute of Harvard and MIT
Jesse S BoehmBroad Institute of Harvard and MIT
William C HahnDana-Farber Cancer Institute
William C HahnBroad Institute of Harvard and MIT
William C HahnBrigham and Women's Hospital
William C HahnDana-Farber Cancer Institute
William C HahnBroad Institute of Harvard and MIT
William C HahnBrigham and Women's Hospital
  • 1 - 35

Datasets

Release 1.2